RT 2000
Alternative Names: RT-2000Latest Information Update: 11 Jul 2025
At a glance
- Originator RenaissThera; VedTechBio
- Developer RenaissThera
- Class Antihyperglycaemics; Obesity therapies; Small molecules
- Mechanism of Action Gastric inhibitory polypeptide receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Obesity; Type 2 diabetes mellitus